Showing 1 - 12 results of 12 for search 'Tindara Franchina', query time: 0.03s Refine Results
  1. 1
    Management of Endocrine and Metabolic Toxicities of Immune-Checkpoint Inhibitors: From Clinical Studies to a Real-Life Scenario

    Management of Endocrine and Metabolic Toxicities of Immune-Checkpoint Inhibitors: From Clinical Studies to a Real-Life Scenario by Calogera Claudia Spagnolo, Giuseppe Giuffrida, Salvatore Cannavò, Tindara Franchina, Nicola Silvestris, Rosaria Maddalena Ruggeri, Mariacarmela Santarpia

    Published 2022-12-01
    Get full text
    Article
  2. 2
    Efficacy of T-DM1 for leptomeningeal and brain metastases in a HER2 positive metastatic breast cancer patient: new directions for systemic therapy - a case report and literature review

    Efficacy of T-DM1 for leptomeningeal and brain metastases in a HER2 positive metastatic breast cancer patient: new directions for systemic therapy - a case report and literature re... by Giuseppina Rosaria Rita Ricciardi, Alessandro Russo, Tindara Franchina, Silvia Schifano, Giampiero Mastroeni, Anna Santacaterina, Vincenzo Adamo

    Published 2018-01-01
    Get full text
    Article
  3. 3
    Renal Disorders with Oral Tyrosine Kinase Inhibitors in Metastatic Colorectal Cancer: An Analysis from the FDA Adverse Event Reporting System Database

    Renal Disorders with Oral Tyrosine Kinase Inhibitors in Metastatic Colorectal Cancer: An Analysis from the FDA Adverse Event Reporting System Database by Giulia Russo, Maria Antonietta Barbieri, Emanuela Elisa Sorbara, Giuseppe Cicala, Tindara Franchina, Mariacarmela Santarpia, Nicola Silvestris, Edoardo Spina

    Published 2023-08-01
    Get full text
    Article
  4. 4
    Neuropsychiatric Adverse Drug Reactions with Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors: An Analysis from the European Spontaneous Adverse Event Reporting System

    Neuropsychiatric Adverse Drug Reactions with Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors: An Analysis from the European Spontaneous Adverse Event Reporting System by Maria Antonietta Barbieri, Emanuela Elisa Sorbara, Giulia Russo, Giuseppe Cicala, Tindara Franchina, Mariacarmela Santarpia, Nicola Silvestris, Edoardo Spina

    Published 2023-03-01
    Get full text
    Article
  5. 5
    Neuropsychiatric adverse drug reactions with oral tyrosine kinase inhibitors in metastatic colorectal cancer: an analysis from the FDA Adverse Event Reporting System

    Neuropsychiatric adverse drug reactions with oral tyrosine kinase inhibitors in metastatic colorectal cancer: an analysis from the FDA Adverse Event Reporting System by Maria Antonietta Barbieri, Giulia Russo, Emanuela Elisa Sorbara, Giuseppe Cicala, Tindara Franchina, Mariacarmela Santarpia, Desirèe Speranza, Edoardo Spina, Nicola Silvestris

    Published 2023-10-01
    Get full text
    Article
  6. 6
    Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients.

    Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients. by Giuseppina Rosaria Rita Ricciardi, Barbara Adamo, Antonio Ieni, Luana Licata, Roberta Cardia, Giuseppa Ferraro, Tindara Franchina, Giovanni Tuccari, Vincenzo Adamo

    Published 2015-01-01
    Get full text
    Article
  7. 7
    Correction: Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients.

    Correction: Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients. by Giuseppina Rosaria Rita Ricciardi, Barbara Adamo, Antonio Ieni, Luana Licata, Roberta Cardia, Giuseppa Ferraro, Tindara Franchina, Giovanni Tuccari, Vincenzo Adamo

    Published 2015-01-01
    Get full text
    Article
  8. 8
    Vaginal Mucosal Melanoma: a Complete Remission after Immunotherapy and '0-7-21' Radiotherapy Regimen (24 Gy/3 fractions/21 days)

    Vaginal Mucosal Melanoma: a Complete Remission after Immunotherapy and '0-7-21' Radiotherapy Regimen (24 Gy/3 fractions/21 days) by Silvana Parisi, Sara Lillo, Alberto Cacciola, Anna Santacaterina, Carmela Palazzolo, Angelo Platania, Nicola Settineri, Tindara Franchina, Consuelo Tamburella, Stefano Pergolizzi

    Published 2020-09-01
    Get full text
    Article
  9. 9
    Safety profile of tyrosine kinase inhibitors used in non-small-cell lung cancer: An analysis from the Italian pharmacovigilance database

    Safety profile of tyrosine kinase inhibitors used in non-small-cell lung cancer: An analysis from the Italian pharmacovigilance database by Maria Antonietta Barbieri, Emanuela Elisa Sorbara, Giuseppe Cicala, Vincenza Santoro, Paola Maria Cutroneo, Tindara Franchina, Mariacarmela Santarpia, Nicola Silvestris, Edoardo Spina

    Published 2022-11-01
    Get full text
    Article
  10. 10
    Immune Checkpoint Inhibitors and the Kidney: A Focus on Diagnosis and Management for Personalised Medicine

    Immune Checkpoint Inhibitors and the Kidney: A Focus on Diagnosis and Management for Personalised Medicine by Elisa Longhitano, Paola Muscolino, Claudia Lo Re, Serena Ausilia Ferrara, Valeria Cernaro, Guido Gembillo, Dalila Tessitore, Desirèe Speranza, Francesco Figura, Mariacarmela Santarpia, Nicola Silvestris, Domenico Santoro, Tindara Franchina

    Published 2023-03-01
    Get full text
    Article
  11. 11
    Therapeutic efficacy of platinum/etoposide regimens in the treatment of advanced poorly differentiated neuroendocrine carcinomas of the lung: A retrospective analysis

    Therapeutic efficacy of platinum/etoposide regimens in the treatment of advanced poorly differentiated neuroendocrine carcinomas of the lung: A retrospective analysis by Ivana Puliafito, Federico Chillari, Alessandro Russo, Ornella Cantale, Dorotea Sciacca, Luigi Castorina, Cristina Colarossi, Tindara Franchina, Maria Paola Vitale, Giuseppina Rosaria Rita Ricciardi, Vincenzo Adamo, Francesca Esposito, Dario Giuffrida

    Published 2023-01-01
    Get full text
    Article
  12. 12
    Polybrominated Diphenyl Ethers (PBDEs) and Human Health: Effects on Metabolism, Diabetes and Cancer

    Polybrominated Diphenyl Ethers (PBDEs) and Human Health: Effects on Metabolism, Diabetes and Cancer by Valerio Renzelli, Marco Gallo, Lelio Morviducci, Giampiero Marino, Alberto Ragni, Enzo Tuveri, Antongiulio Faggiano, Rossella Mazzilli, Annalisa Natalicchio, Maria Chiara Zatelli, Monica Montagnani, Stefano Fogli, Dario Giuffrida, Antonella Argentiero, Romano Danesi, Stella D’Oronzo, Stefania Gori, Tindara Franchina, Antonio Russo, Matteo Monami, Laura Sciacca, Saverio Cinieri, Annamaria Colao, Angelo Avogaro, Graziano Di Cianni, Francesco Giorgino, Nicola Silvestris

    Published 2023-08-01
    Get full text
    Article

Search Tools: